Avenue Therapeutics to Participate in Upcoming Investor Conferences
September 03, 2024 08:30 ET
|
Avenue Therapeutics
MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of...
The Lee Health Heart Institute Offers Endoscopic Heart Valve Repair Surgery, Putting the Health System at the Forefront of Cardiac Care
August 29, 2024 11:00 ET
|
Lee Health
Fort Myers, Florida, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Lee Health is thrilled to announce that it has completed the first fully endoscopic heart valve surgery through the smallest incision possible,...
Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
August 09, 2024 16:05 ET
|
Avenue Therapeutics
- Last patient visit complete in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data anticipated in second half of 2024 – - Raised $4.4 million in gross proceeds...
Calfee, Halter & Griswold LLP Named Leading Law Firm by Chambers High Net Worth 2024
July 23, 2024 12:47 ET
|
Calfee, Halter & Griswold LLP
Cleveland, July 23, 2024 (GLOBE NEWSWIRE) -- Calfee, Halter & Griswold’s Estate and Succession Planning and Administration group has been ranked as a Leading Law Firm in Ohio (Band 1) in Private...
AFCI Expands Industry Access to Global Film Commissioner Conference
July 12, 2024 13:21 ET
|
AFCI
AFCI Week in Los Angeles opens attendance to production industry professionals; MPA Chair and CEO Charles Rivkin to deliver keynote address.
Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
June 21, 2024 16:01 ET
|
Mustang Bio, Inc.
WORCESTER, Mass., June 21, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical...
Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
June 20, 2024 08:30 ET
|
Avenue Therapeutics
MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of...
Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
June 20, 2024 08:00 ET
|
Mustang Bio, Inc.
WORCESTER, Mass., June 20, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical...
Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy
June 17, 2024 08:30 ET
|
Mustang Bio, Inc.
Overall response rate of 90% in cohort with durable responses observed; one patient remains in complete remission at 31 months All patients were heavily pretreated/refractory to BTK inhibitors, and...
Calfee, Halter & Griswold LLP Named Leading Law Firm by Chambers USA 2024
June 07, 2024 15:39 ET
|
Calfee, Halter & Griswold LLP
Cleveland, June 07, 2024 (GLOBE NEWSWIRE) -- Calfee, Halter & Griswold LLP has been recognized as a 2024 Leading Law Firm in Ohio, Indiana, Washington, D.C., and nationally in the recently...